KD025 (Belumosudil)
Selleck Chemicals
SKU:S7936-5MG
Couldn't load pickup availability

KD025 (Belumosudil) is an inhibitor of ROCK2 used in studies of kinase signaling. It is especially relevant in cancer, cardiovascular, and cell cycle models, where defined compound exposure can be linked to phosphorylation signaling, target engagement, and selectivity relationships.
By inhibiting ROCK2, KD025 (Belumosudil) can be used to examine phosphorylation signaling, target engagement, and selectivity relationships. This target class is commonly examined through biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping. In cancer, cardiovascular, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving ROCK2
- Concentration-response inhibition and target-dependence studies
- Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
- Phenotypic profiling in cancer, cardiovascular, and cell cycle models
Overall, KD025 (Belumosudil) is appropriate when a defined chemical perturbant is needed to connect ROCK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cardiovascular, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- ROCK2
- Target Class:
- Kinase
- Research Area:
- Cancer • Cardiovascular • Cell Cycle • Cell Signaling
- CAS No.:
- 911417-87-3
- Molecular Weight:
- 452.51
- Formula:
- C₂₆H₂₄N₆O₂
- SMILES:
- CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.